Literature DB >> 29929610

Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study.

Mauro Maioli1, Anna Toso2, Mario Leoncini1, Nicola Musilli1, Gabriele Grippo1, Claudio Ronco3, Peter A McCullough4, Francesco Bellandi1.   

Abstract

BACKGROUND: Intravascular volume expansion plays a major role in the prevention of contrast-induced acute kidney injury (CI-AKI). Recommended standard amounts of fluid infusion before procedures do not produce homogeneous responses in subjects with different initial hydration status.
OBJECTIVES: The goal of this study was to compare the effect of standard and double intravenous (IV) infusion volumes in patients with low body fluid level, assessed by using bioimpedance vector analysis (BIVA), on the incidence of CI-AKI after elective coronary angiographic procedures.
METHODS: A total of 303 patients with low BIVA level on admission were randomized to receive standard volume saline (1 ml/kg/h for 12 h before and after the procedure) or double volume saline (2 ml/kg/h). Patients (n = 715) with an optimal BIVA level received standard volume saline and were included in a prospective registry. The saline infusion was halved in all patients with an ejection fraction <40%. BIVA was repeated immediately before the angiographic procedure in all patients. CI-AKI was defined as an increase in levels of cystatin C ≥10% above baseline at 24 h after contrast administration.
RESULTS: The incidence of CI-AKI was significantly lower (11.5% vs. 22.3%; p = 0.015) in patients receiving double volume saline than in those receiving standard volume saline, respectively. Before the angiographic procedure, 50% of the double volume patients achieved the optimal BIVA level compared with only 27.7% in the standard group (p = 0.0001). The findings were consistent in all the pre-specified subgroups excluding patients with a left ventricular ejection fraction <40% (p for interaction = 0.01).
CONCLUSIONS: Evaluation of BIVA levels on admission in patients with stable coronary artery disease allows adjustment of intravascular volume expansion, resulting in lower CI-AKI occurrence after angiographic procedures. (Personalized Versus Standard Hydration for Prevention of CI-AKI: A Randomized Trial With Bioimpedance Analysis; NCT02225431).
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiography; bioimpedance vector analysis; contrast-induced acute kidney injury

Mesh:

Substances:

Year:  2018        PMID: 29929610     DOI: 10.1016/j.jacc.2018.04.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.

Authors:  Armin Marashizadeh; Hamid Reza Sanati; Parham Sadeghipour; Mohamad Mehdi Peighambari; Jamal Moosavi; Omid Shafe; Ata Firouzi; Ali Zahedmehr; Mohsen Maadani; Farshad Shakerian; Reza Kiani; Bahram Mohebbi; Mohammad Javad Alemzadeh-Ansari; Reza Tahvili; Batoul Naghavi
Journal:  Int Urol Nephrol       Date:  2019-07-22       Impact factor: 2.370

2.  Simple pre-procedure risk stratification tool for contrast-induced nephropathy.

Authors:  Zhonghan Ni; Yan Liang; Nianjin Xie; Jin Liu; Guoli Sun; Shiqun Chen; Jianfeng Ye; Yibo He; Wei Guo; Ning Tan; Jiyan Chen; Yong Liu; Zhujun Chen; Shouhong Wang
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Bioimpedance Analysis-Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial).

Authors:  Sarassawan Kananuraks; Montira Assanatham; Sarinya Boongird; Chagriya Kitiyakara; Kanin Thammavaranucupt; Thosaphol Limpijarnkij; Daruneewan Warodomwichit; Andrew Davenport; Arkom Nongnuch
Journal:  Kidney Int Rep       Date:  2020-07-17

4.  Relationship Between Bioimpedance Vector Displacement and Renal Function After a Marathon in Non-elite Runners.

Authors:  Lexa Nescolarde; Emma Roca; Paco Bogónez-Franco; José Hernández-Hermoso; Antoni Bayes-Genis; Jordi Ara
Journal:  Front Physiol       Date:  2020-05-06       Impact factor: 4.566

5.  Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis.

Authors:  Qiuping Cai; Ran Jing; Wanfen Zhang; Yushang Tang; Xiaoping Li; Tongqiang Liu
Journal:  J Interv Cardiol       Date:  2020-02-11       Impact factor: 2.279

Review 6.  Contrast-Associated Acute Kidney Injury: Advances and Challenges.

Authors:  Qingqing Li; Shengqi Pan
Journal:  Int J Gen Med       Date:  2022-02-15

7.  Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis.

Authors:  Rui Hua; Ning Ding; Hanqing Guo; Yue Wu; Zuyi Yuan; Ting Li
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 8.  The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy.

Authors:  Eunjung Cho; Gang-Jee Ko
Journal:  Diagnostics (Basel)       Date:  2022-01-12

9.  Association of dialysis-requiring acute kidney injury with 90-day prognosis in patients with coronary artery disease and advanced kidney disease after coronary angiography.

Authors:  Guanzhong Chen; Xiaoming Yan; Zhidong Huang; Liwei Liu; Liangguang Meng; Min Li; Jin Liu; Shiqun Chen; Huanqiang Li; Ziling Mai; Enzhao Chen; Disheng Lai; Bo Wang; Haozhang Huang; Ning Tan; Yong Liu; Shuisheng Wei; Jiyan Chen
Journal:  Ann Transl Med       Date:  2020-10

10.  Trends in incidence and long-term prognosis of acute kidney injury following coronary angiography in Chinese cohort with 11,943 patients from 2013 to 2017: an observational study.

Authors:  Jin Liu; Qiang Li; Disheng Lai; Guoqin Chen; Bo Wang; Liwei Liu; Haozhang Huang; Zhubin Lun; Ming Ying; Guanzhong Chen; Zhidong Huang; Danyuan Xu; Liangguang Meng; Xiaoming Yan; Weiyan Qiu; Ning Tan; Jiyan Chen; Yong Liu; Shiqun Chen
Journal:  BMC Nephrol       Date:  2021-06-25       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.